|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Aerovate Therapeutics, Inc. (AVTE) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
27,670,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$ - $ |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Aerovate Therapeutics is a clinical stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Co.'s initial focus is on improving AV-101, its dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension. AV-101, delivered using a dry powder inhaler, is designed to provide lung concentrations at or above those observed with the oral dose while limiting systemic levels of the drug.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
198,525 |
283,422 |
343,887 |
1,083,676 |
Total Sell Value |
$5,199,454 |
$6,632,651 |
$7,649,183 |
$16,638,542 |
Total People Sold |
6 |
7 |
7 |
8 |
Total Sell Transactions |
25 |
38 |
50 |
111 |
End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Dake Benjamin T |
SEE REMARKS |
|
2022-10-17 |
4 |
AS |
$20.16 |
$84,380 |
D/D |
(4,185) |
0 |
|
- |
|
Dake Benjamin T |
SEE REMARKS |
|
2022-10-17 |
4 |
OE |
$2.14 |
$8,956 |
D/D |
4,185 |
4,185 |
|
- |
|
Dake Benjamin T |
SEE REMARKS |
|
2022-10-14 |
4 |
AS |
$20.05 |
$2,206 |
D/D |
(110) |
0 |
|
- |
|
Dake Benjamin T |
SEE REMARKS |
|
2022-10-14 |
4 |
OE |
$2.14 |
$235 |
D/D |
110 |
110 |
|
- |
|
Dake Benjamin T |
SEE REMARKS |
|
2022-10-10 |
4 |
AS |
$16.74 |
$83,681 |
D/D |
(4,954) |
0 |
|
- |
|
Dake Benjamin T |
SEE REMARKS |
|
2022-10-10 |
4 |
OE |
$2.14 |
$10,602 |
D/D |
4,954 |
4,954 |
|
- |
|
Dake Benjamin T |
SEE REMARKS |
|
2022-10-07 |
4 |
AS |
$15.93 |
$168,460 |
D/D |
(10,520) |
0 |
|
- |
|
Dake Benjamin T |
SEE REMARKS |
|
2022-10-07 |
4 |
OE |
$2.14 |
$22,513 |
D/D |
10,520 |
10,520 |
|
- |
|
Dake Benjamin T |
SEE REMARKS |
|
2022-10-06 |
4 |
AS |
$15.64 |
$206,344 |
D/D |
(13,040) |
0 |
|
- |
|
Dake Benjamin T |
SEE REMARKS |
|
2022-10-06 |
4 |
OE |
$1.74 |
$26,941 |
D/D |
13,040 |
13,040 |
|
- |
|
Niven Ralph |
CHIEF SCIENTIFIC OFFICER |
|
2022-10-05 |
4 |
AS |
$15.71 |
$35,447 |
D/D |
(2,250) |
1,609 |
|
- |
|
Niven Ralph |
CHIEF SCIENTIFIC OFFICER |
|
2022-10-05 |
4 |
OE |
$1.74 |
$4,555 |
D/D |
2,250 |
3,859 |
|
- |
|
Dake Benjamin T |
SEE REMARKS |
|
2022-09-12 |
4 |
AS |
$16.90 |
$130,307 |
D/D |
(7,520) |
0 |
|
- |
|
Dake Benjamin T |
SEE REMARKS |
|
2022-09-12 |
4 |
OE |
$2.14 |
$16,093 |
D/D |
7,520 |
7,520 |
|
- |
|
Dake Benjamin T |
See Remarks |
|
2022-09-09 |
4 |
AS |
$17.50 |
$82,803 |
D/D |
(4,720) |
0 |
|
- |
|
Dake Benjamin T |
See Remarks |
|
2022-09-09 |
4 |
OE |
$1.74 |
$9,998 |
D/D |
4,720 |
4,720 |
|
- |
|
Dake Benjamin T |
See Remarks |
|
2022-09-08 |
4 |
AS |
$18.14 |
$56,782 |
D/D |
(3,120) |
0 |
|
- |
|
Dake Benjamin T |
See Remarks |
|
2022-09-08 |
4 |
OE |
$1.74 |
$5,429 |
D/D |
3,120 |
3,120 |
|
- |
|
Dake Benjamin T |
See Remarks |
|
2022-09-07 |
4 |
AS |
$18.12 |
$67,469 |
D/D |
(3,663) |
0 |
|
- |
|
Dake Benjamin T |
See Remarks |
|
2022-09-07 |
4 |
OE |
$1.74 |
$14,303 |
D/D |
8,220 |
8,220 |
|
- |
|
Dake Benjamin T |
See Remarks |
|
2022-09-06 |
4 |
AS |
$17.94 |
$169,876 |
D/D |
(9,166) |
0 |
|
- |
|
Dake Benjamin T |
See Remarks |
|
2022-09-06 |
4 |
OE |
$1.74 |
$15,949 |
D/D |
9,166 |
9,166 |
|
- |
|
Niven Ralph |
Chief Scientific Officer |
|
2022-09-06 |
4 |
AS |
$19.00 |
$42,750 |
D/D |
(2,250) |
1,609 |
|
- |
|
Niven Ralph |
Chief Scientific Officer |
|
2022-09-06 |
4 |
OE |
$1.74 |
$4,555 |
D/D |
2,250 |
3,859 |
|
- |
|
Niven Ralph |
Chief Scientific Officer |
|
2022-08-18 |
4 |
AS |
$21.18 |
$47,657 |
D/D |
(2,250) |
1,609 |
|
- |
|
225 Records found
|
|
Page 8 of 9 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|